Suppr超能文献

鉴定恰加斯病患者识别的克氏锥虫热休克蛋白 70 中 HLA-A∗02:01 限制性 CTL 表位。

Identification of HLA-A∗02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients.

机构信息

Instituto de Parasitología y Biomedicina López Neyra (CSIC), Parque Tecnológico de Ciencias de la Salud, Avda. del Conocimiento S/N, 18100 Armilla, Spain.

出版信息

Microbes Infect. 2011 Nov;13(12-13):1025-32. doi: 10.1016/j.micinf.2011.05.010. Epub 2011 Jun 12.

Abstract

CD8(+) cytotoxic T lymphocyte (CTL) response is critical for controlling the infection of the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas disease. Since only a few CD8 antigens have been described in Chagas disease patients, the identification of new class I-restricted epitopes is urgently needed for the development of immunotherapies against T. cruzi infection. In this study, bioinformatic methods were used to predict HLA-A∗02:01-binders, and 30 peptides were selected, synthesized and tested for HLA-A∗02:01 binding. Among them, sixteen peptides with medium-to-high affinity were assayed for their recognition by CTL from HSP70-immunized or T. cruzi-infected transgenic B6-A2/K(b) mice. Our results show that four immunodominant epitopes (HSP70(210-8), HSP70(255-63), HSP70(316-24) and HSP70(345-53)) are contained in the T. cruzi HSP70 antigen. Indeed two of them (HSP70(210-8) and HSP70(316-24)) were also recognized by CTL of HLA-A∗02:01(+) Chagas disease patients, indicating that these peptides are processed and displayed as MHC class I epitopes during the natural history of T. cruzi infection. The HLA-A∗02:01 restriction was evidenced using peptide-pulsed K562-A2 cells as antigen-presenting cells. Both cytotoxic and cytokine-secreting activities were detected in response to the former two peptides and, moreover, 10/12 patients (83%) recognized at least one of these two HSP70-derived CD8(+) epitopes.

摘要

CD8(+)细胞毒性 T 淋巴细胞 (CTL) 反应对于控制原生动物寄生虫克氏锥虫的感染至关重要,克氏锥虫是恰加斯病的病原体。由于在恰加斯病患者中仅描述了少数 CD8 抗原,因此迫切需要鉴定新的 I 类限制表位,以开发针对 T. cruzi 感染的免疫疗法。在这项研究中,使用生物信息学方法预测 HLA-A∗02:01 结合物,并选择 30 个肽进行合成和 HLA-A∗02:01 结合测试。其中,对具有中至高亲和力的 16 个肽进行了测定,以评估其对 HSP70 免疫或 T. cruzi 感染转基因 B6-A2/K(b)小鼠 CTL 的识别。我们的结果表明,T. cruzi HSP70 抗原中包含四个免疫优势表位 (HSP70(210-8)、HSP70(255-63)、HSP70(316-24) 和 HSP70(345-53))。事实上,其中两个(HSP70(210-8)和 HSP70(316-24))也被 HLA-A∗02:01(+)恰加斯病患者的 CTL 识别,表明这些肽在 T. cruzi 感染的自然史中作为 MHC 类 I 表位被加工和呈递。使用肽脉冲 K562-A2 细胞作为抗原呈递细胞证明了 HLA-A∗02:01 限制。针对前两个肽检测到细胞毒性和细胞因子分泌活性,此外,10/12 名患者(83%)至少识别出这两个 HSP70 衍生 CD8(+)表位中的一个。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验